Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Published by: Institute for Management Development (IMD)
Originally published in: 2019
Version: 01.02.2019
Revision date: 16-Apr-2019

Abstract

The case examines the decisions and actions taken by ResMed's company leadership over a five-year period to transform the maker of medical devices for sleep apnea from a product-focused business into a 'health informatics' company. While the company had a long and successful history of growth and innovation, company leaders anticipated radical change in the market, including competitive threats from lower-cost rivals as well as a shifting landscape for healthcare reimbursement in the United States, ResMed's largest market. Beginning with the acquisition of a specialized healthcare data analytics company in 2012, ResMed invested heavily in new device platforms and software that enabled it to gather and analyze a vast quantity of patient data. The information gathered through the company's CPAP devices could be used to improve patient care and enhance profitability for ResMed's Home Medical Equipment (HME) customers. The strategy, however, required a wholesale transformation of all aspects of the company's operations and marketing processes to deliver and communicate the value of its new offerings. ResMed's leaders also faced the challenge of explaining and justifying to investors how the new 'connected care' strategy produced value for the company. The case explores a number of key decisions related to technology choices, pricing strategy, and the integration of software capabilities into a company that had traditionally focused on product engineering. The case also looks at ResMed's decision to 'double down' on its digital transformation with the acquisition in 2016 of Brightree, a provider of cloud-based clinical, billing and business management solutions for healthcare customers.

Time period

The events covered by this case took place in 2016-2018.

Geographical setting

Region:
Americas
Country:
United States

Featured company

ResMed
Turnover:
USD 2.3 billion
Industry:
Prosthetics industry

About

Abstract

The case examines the decisions and actions taken by ResMed's company leadership over a five-year period to transform the maker of medical devices for sleep apnea from a product-focused business into a 'health informatics' company. While the company had a long and successful history of growth and innovation, company leaders anticipated radical change in the market, including competitive threats from lower-cost rivals as well as a shifting landscape for healthcare reimbursement in the United States, ResMed's largest market. Beginning with the acquisition of a specialized healthcare data analytics company in 2012, ResMed invested heavily in new device platforms and software that enabled it to gather and analyze a vast quantity of patient data. The information gathered through the company's CPAP devices could be used to improve patient care and enhance profitability for ResMed's Home Medical Equipment (HME) customers. The strategy, however, required a wholesale transformation of all aspects of the company's operations and marketing processes to deliver and communicate the value of its new offerings. ResMed's leaders also faced the challenge of explaining and justifying to investors how the new 'connected care' strategy produced value for the company. The case explores a number of key decisions related to technology choices, pricing strategy, and the integration of software capabilities into a company that had traditionally focused on product engineering. The case also looks at ResMed's decision to 'double down' on its digital transformation with the acquisition in 2016 of Brightree, a provider of cloud-based clinical, billing and business management solutions for healthcare customers.

Settings

Time period

The events covered by this case took place in 2016-2018.

Geographical setting

Region:
Americas
Country:
United States

Featured company

ResMed
Turnover:
USD 2.3 billion
Industry:
Prosthetics industry

Related